Catherine Novack
Stock Analyst at Jones Trading
(0.08)
# 2656
Out of 5,347 analysts
24
Total ratings
30.77%
Success rate
-6.62%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
FEMY Femasys | Maintains: Buy | 10 6 | 0.88 | 581.82% | 2 | May 13, 2025 | |
RGLS Regulus Therapeutics | Downgrades: Hold | 8 7 | 7.94 | -11.84% | 2 | Apr 30, 2025 | |
RLYB Rallybio | Downgrades: Hold | n/a | n/a | n/a | 1 | Apr 15, 2025 | |
PVLA Palvella Therapeutic... | Initiates Coverage On: Buy | 45 | 24.23 | 85.72% | 1 | Mar 25, 2025 | |
PRQR ProQR Therapeutics | Initiates Coverage On: Buy | 11 | 1.66 | 562.65% | 1 | Feb 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 130 | 11.46 | 1034.38% | 1 | Nov 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 40 | 9.9 | 304.04% | 1 | Nov 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Nov 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Oct 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 12 16 | 6.01 | 166.22% | 2 | Sep 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 14 | 2.24 | 525% | 1 | Sep 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 5 13 | 2.89 | 349.83% | 2 | Aug 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 4.11 | 143.31% | 1 | Apr 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 22 | 1.71 | 1186.55% | 1 | Feb 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Oct 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 160 | 2.67 | 5892.51% | 1 | Jul 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 11 | n/a | n/a | 1 | Mar 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 25 | n/a | n/a | 1 | Dec 2, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 45 | n/a | n/a | 1 | Oct 4, 2021 |